跳至主要内容
临床试验/NCT06711679
NCT06711679Enrolling By Invitation4 期

Exploring the Minimum Effective Concentration and Volume of Ropivacaine for Sacral Plexus Anesthesia in Children of Different Ages

Yilin Zhao1 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2024年5月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
Enrolling By Invitation
发起方
入组人数
180
试验地点
1
主要终点
Distribution and block plane in the spinal canal after caudal injection of different doses of ropivacaine.

研究概览

简要总结

The goal of this clinical trial is to explore the minimum effective concentration and volume of ropivacaine for sacral plexus anesthesia. The main questions it aims to answer are:

  • The distribution of different volumes of ropivacaine after caudal anesthesia
  • The blockade level after caudal anesthesia with varying doses
  • The minimum effective concentration of ropivacaine among pediatric patients of different age groups Researchers will inject different doses or concentrations of ropivacaine into the caudal canal to observe the drug's spread range, the level of blockade, and the duration of its effect.

Participants will:

  • Undergo magnetic resonance imaging (MRI) examinations before and after caudal anesthesia
  • Will be detected the blockade level after caudal anesthesia

详细描述

The activity of CYP1A2 in newborns and infants is lower than in adults, which may result in slower metabolism of ropivacaine. This might necessitate a reduction in the dosage or concentration of ropivacaine to prevent drug accumulation and toxicity. Additionally, since the nervous system in children is still developing, excessively high concentrations of ropivacaine could have adverse effects. Therefore, the lowest effective concentration of ropivacaine should be chosen to minimize the risk of adverse reactions. Generally, the dosage of ropivacaine should be determined based on the patient's age, weight, and the type of surgery. However, there are currently no definitive dosage recommendations, and further research is needed to determine these guidelines.

The goal of this clinical trial is to exploring the minimum effective concentration and volume of ropivacaine for sacral plexus anesthesia. Using MRI to investigate the distribution of different doses of ropivacaine after caudal anesthesia, and employing infrared imaging technology to detect the blockade level after caudal anesthesia with varying doses.

Participants will receive 0.5ml/Kg, 1ml/Kg and 1.5ml/Kg ropivacaine, then undergo magnetic resonance imaging (MRI) examinations to detect the distribution and optic nerve sheath diameter (ONSD) before and after caudal injection. Also, the blockade level will be detected 15min and 30 min after caudal anesthesia

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
1 Day 至 7 Years(Child)
性别
All
接受健康志愿者

入选标准

  • BMI ≤ 30 kg/m²; lower limbs surgery; lower abdomen surgery; perineal region surgery; Normal liver and kidney function; Normal coagulation function; Hemoglobin > 70 g/L.

排除标准

  • Abnormal coagulation function; Allergy to local anesthetics; Abnormal sacral anatomy; Puncture site infection;

研究组 & 干预措施

Child Group

Experimental

3-7 years

干预措施: Low-dose ropivacaine (Drug)

Child Group

Experimental

3-7 years

干预措施: Medium-dose of ropivacaine (Drug)

Neonatal group

Experimental

From birth to 28 days

干预措施: Low-dose ropivacaine (Drug)

Neonatal group

Experimental

From birth to 28 days

干预措施: Medium-dose of ropivacaine (Drug)

Neonatal group

Experimental

From birth to 28 days

干预措施: High-dose ropivacaine (Drug)

Infant group

Experimental

1 month to 1 year

干预措施: Low-dose ropivacaine (Drug)

Infant group

Experimental

1 month to 1 year

干预措施: Medium-dose of ropivacaine (Drug)

Infant group

Experimental

1 month to 1 year

干预措施: High-dose ropivacaine (Drug)

Toddler Group

Experimental

1-3 years

干预措施: Low-dose ropivacaine (Drug)

Toddler Group

Experimental

1-3 years

干预措施: Medium-dose of ropivacaine (Drug)

Toddler Group

Experimental

1-3 years

干预措施: High-dose ropivacaine (Drug)

Child Group

Experimental

3-7 years

干预措施: High-dose ropivacaine (Drug)

结局指标

主要结局

Distribution and block plane in the spinal canal after caudal injection of different doses of ropivacaine.

时间窗: 30 minutes

MRI scan will be performed before and after 0.5 ml/Kg, 1,ml/Kg, or 1.5ml/Kg ropivacaine injection,

The blockade level after caudal anesthesia with varying doses

时间窗: 60 minutes

The blockade level will be tested 15 min and 30min after 0.5 ml/Kg, 1,ml/Kg, or 1.5ml/Kg ropivacaine injection. The infrared imaging technology will be employed to test the blockade level.

The minimum effective concentration of ropivacaine among pediatric patients of different age groups

时间窗: 2 days

The fixed capacity requires the minimum effective concentration by changing the concentration

次要结局

  • Effects ofMedium-dose and high-dose of ropivacaine injection on Optic Nerve Sheath Diameter (ONSD) and blood brain barrier(60 minutes)
  • Effects of different volumes and concentrations of ropivacaine on heart rate(2 days)
  • Effects of different volumes and concentrations of ropivacaine on blood pressure(2 days)
  • Effects of different volumes and concentrations of ropivacaine on oxygenation(2 days)
  • To evaluate the relaxation degree of anal sphincter after sacral anesthesia(30 minutes)

研究者

发起方
Yilin Zhao
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Yilin Zhao

Principal Investigator

Tongji Hospital

研究点 (1)

Loading locations...

相似试验